| Product NDC: | 64253-202 |
| Proprietary Name: | sodium chloride |
| Non Proprietary Name: | sodium chloride |
| Active Ingredient(s): | 9 mg/mL & nbsp; sodium chloride |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64253-202 |
| Labeler Name: | Medefil, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202832 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120113 |
| Package NDC: | 64253-202-30 |
| Package Description: | 60 SYRINGE, PLASTIC in 1 BOX (64253-202-30) > 10 mL in 1 SYRINGE, PLASTIC |
| NDC Code | 64253-202-30 |
| Proprietary Name | sodium chloride |
| Package Description | 60 SYRINGE, PLASTIC in 1 BOX (64253-202-30) > 10 mL in 1 SYRINGE, PLASTIC |
| Product NDC | 64253-202 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sodium chloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20120113 |
| Marketing Category Name | NDA |
| Labeler Name | Medefil, Inc. |
| Substance Name | SODIUM CHLORIDE |
| Strength Number | 9 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |